MannKind CEO Michael PharmD's 2019 pay rises 3% to $1.6M
MannKind reports 2019 executive compensation
By ExecPay News
Published: April 10, 2020
MannKind reported fiscal year 2019 executive compensation information on April 10, 2020.
In 2019, five MannKind executives received on average a compensation package of $1.1M, a 7% decrease compared to previous year.
Average pay of disclosed executives at MannKind
Michael E. Castagna, PharmD, Chief Executive Officer, received $1.6M in total, which increased by 3% compared to 2018. 40% of PharmD's compensation, or $618K, was in option awards. PharmD also received $285K in non-equity incentive plan, $511K in salary, $90K in stock awards, as well as $48K in other compensation.
For fiscal year 2019, the median employee pay was $148,059 at MannKind. Therefore, the ratio of Michael E. Castagna, PharmD's pay to the median employee pay was 10 to one.
David M. Kendall, Chief Medical Officer, received a compensation package of $1M, which decreased by 12% compared to previous year. 43% of the compensation package, or $434K, was in salary.
David Thomson, General Counsel, earned $988K in 2019, a 8% increase compared to previous year.
Steven B. Binder, Chief Financial Officer, received $938K in 2019, which increases by 10% compared to 2018.
James P. McCauley, Jr, Chief Commercial Officer, earned $922K in 2019, a 14% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 10, 2020.